Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders

Author(s): Lee JY, Seo SH, Kim YK, Yoo HB, Kim YE, et al.


Objective:To investigate the extrastriatal dopaminergic neural changes in relation to the medication-related impulse control disorders (ICD) in Parkinson's disease (PD).

Method:A total of 31 subjects (11 and 11 drug-treated PD patients with and without medication-related ICDs and 9 healthy controls) having no other co-morbid psychiatric disorders participated in this study. Each subject underwent dynamic N-(3-[(18)F]fluoropropyl)-2-carbomethoxy-3-(4-iodophenyl) nortropane (FP-CIT) positron emission tomography scans. Binding potentials (BP) at nucleus accumbens, amygdala, orbitofrontal and ventromedial prefrontal cortex (VMPFC), putamen and caudate nucleus were estimated, and whole brain parametric maps of [(18)F]-FP-CIT binding were analysed by original and putaminal normalised manners.

Results:Compared with the healthy controls, BPs at both VMPFCs were significantly high and the extrastriatal to putaminal BP ratios at all regions were approximately three times higher in both PD groups. The PD ICD patients showed significantly higher BPs at the right VMPFC and tendency to lower BPs at the left nucleus accumbens compared with those free of ICD. The ICD subjects also showed reduced uptakes at both ventral striatal regions in the original parametric analysis and higher uptakes at the left insular and right posterior cingulate cortex and lower uptakes at both ventral pallidums in the putaminal normalised parametric analysis compared with the non-ICD subjects.

Conclusions:A great gap in extrastriatal versus striatal dopaminergic fibre degenerations is an intrinsic condition predisposing to ICD in PD. Distinct pattern of extrastriatal changes between the ICD and non-ICD patients could provide a further insight into a mechanism of ICD in PD.

Similar Articles

Clinical features associated with impulse control disorders in Parkinson disease

Author(s): Pontone G, Williams JR, Bassett SS, Marsh L

Behavioural disorders, disability and quality of life in Parkinson's disease

Author(s): Leroi I, Ahearn DJ, Andrews M, McDonald KR, Byrne EJ, et al.

Carer burden in apathy and impulse control disorders in Parkinson's disease

Author(s): Leroi I, Harbishettar V, Andrews M, McDonald K, Byrne EJ, et al.

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

Author(s): Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, et al.

Apathy is associated with a single-nucleotide polymorphism in a dopamine-related gene

Author(s): Mitaki S, Isomura M, Maniwa K, Yamasaki M, Nagai A, et al.

Impulse control disorders in Parkinson disease: a multicenter case--control study

Author(s): Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, et al.

Association of dopamine agonist use with impulse control disorders in Parkinson disease

Author(s): Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, et al.

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

Author(s): Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, et al.

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease

Author(s): Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, et al.

Novelty seeking and introversion do not predict the long-term risk of Parkinson disease

Author(s): Arabia G, Grossardt BR, Colligan RC, Bower JH, Maraganore DM, et al.

An exploration of apathy and impulsivity in Parkinson disease

Author(s): Ahearn DJ, McDonald K, Barraclough M, Leroi I

Apathy and impulse control disorders in Parkinson's disease: a direct comparison

Author(s): Leroi I, Andrews M, McDonald K, Harbishettar V, Elliott R, et al.

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Author(s): Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, et al.

Reliability, validity, and clinical correlates of apathy in Parkinson's disease

Author(s): Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, et al.

Reliability and validity of the Apathy Evaluation Scale

Author(s): Marin RS, Biedrzycki RC, Firinciogullari S

Factor structure of the Barratt impulsiveness scale

Author(s): Patton JH, Stanford MS, Barratt ES

The hospital anxiety and depression scale

Author(s): Zigmond AS, Snaith RP

Systematic review of levodopa equivalency reporting in parkinson’s disease

Author(s): Tomilson CL, Stawe R, Patel S, Rick C, Gray R, et al.

Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study

Author(s): Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, et al.

Personality traits in young patients with Parkinson's disease

Author(s): Jacobs H, Heberlein I, Vieregge A, Vieregge P

Premorbid personality and behavioral and psychological symptoms in probable Alzheimer disease

Author(s): Archer N, Brown RG, Reeves SJ, Boothby H, Nicholas H, et al.